Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Zhang, A; Geisler, S C; Smith, A D et al. (1999) A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1. Biol Chem 380:365-74
Kraus, G; Radaelli, A; Talbott, R et al. (1998) Characterization of a molecular clone of HIV type 2 infectious for Macaca nemestrina. AIDS Res Hum Retroviruses 14:65-77
Looney, D J; McClure, J; Kent, S J et al. (1998) A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2(287) challenge. Virology 242:150-60
Radaelli, A; Kraus, G; Schmidt, A et al. (1998) Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model. J Virol 72:7871-84
Arnold, G F; Resnick, D A; Smith, A D et al. (1996) Chimeric rhinoviruses as tools for vaccine development and characterization of protein epitopes. Intervirology 39:72-8
Mosier, D E (1996) Small animal models for acquired immune deficiency syndrome (AIDS) research. Lab Anim Sci 46:257-65
Mamounas, M; Looney, D J; Talbott, R et al. (1995) An infectious chimeric human immunodeficiency virus type 2 (HIV-2) expressing the HIV-1 principal neutralizing determinant. J Virol 69:6424-9
Reddy, T R; Kraus, G; Yamada, O et al. (1995) Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. J Virol 69:3549-53
Mosier, D E (1995) Distinct rate and patterns of human CD4+ T-cell depletion in hu-PBL-SCID mice infected with different isolates of the human immunodeficiency virus. J Clin Immunol 15:130S-133S
Reddy, T R; Kraus, G; Suhasini, M et al. (1995) Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene. J Virol 69:5167-70

Showing the most recent 10 out of 25 publications